A number of strategies have been identified that increase the inclusion level of exon 20 in cells derived from FD patients or FD mouse models, and a platform has been developed to screen for potential small molecules that can affect IKBKAP splicing [25–29]. Here, ELP1 is linked to Fabry disease.